/R E P E A T -- MEDIA ADVISORY - Government of Canada to make announcement for Canadian Armed Forces in Sherbrooke/
SHERBROOKE, QC, Aug. 2, 2021 /CNW/ - On behalf of the Honourable Anita Anand, Minister of Public Services and Procurement, the Honourable Marie-Claude Bibeau, Minister of Agriculture and Agri-Food, will make an announcement about a contract for the Canadian Armed Forces in Sherbrooke. This contract will ensure that the members of the Canadian Armed Forces have the equipment they need to fulfill their commitment to serving Canadians at home and abroad.
Date:
Tuesday, August 3, 2021
Time:
2 pm
Location:
ROYER
5085 Robert-Boyd Street
Sherbrooke, Quebec
As space is limited, media wanting to attend this press conference must confirm their presence by sending an email to the Media Relations team by 10 am on Tuesday, August 3, 2021, at the following address: [email protected].
Anyone attending the press conference must not present any symptoms similar to those of COVID-19 and must not have been in contact with anyone who has received a positive diagnosis within the last 14 days. Note that face masks or coverings must be worn.
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...
